FDA
-
-
-
-
-
-
-
Sunshine Biopharma Expands Board of Directors
-
-
-
-
-
-
-
Sunshine Biopharma’s Adva-27a Destroys Cancer Cells Expressing P-glycoprotein, a Marker Present in Over 50% of All Cancer Types
-
-
-
-
-
-
-
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Europe Until 2033
330,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

